Budesonide can be nebulized along with Ambroxol Hydrochloride Solution for Inhalation. Budesonide is nebulized in the form of Budesonide Suspension for Inhalation and Budesonide Nebulized Inhalation Suspension, which has anti-inflammatory properties and is used to treat bronchial asthma. The dosage is administered via a nebulizer. Adverse reactions include respiratory infections, cough, rhinitis, otitis media, viral infections, and candidiasis. The drug is contraindicated in people who are allergic to its components. Ambroxol Hydrochloride Solution for Inhalation has the effect of promoting sputum expectoration and is used for expectorant treatment of lung diseases such as bronchitis and bronchial asthma in people with abnormal sputum secretion and poor sputum expectoration function. This product is used by inhalation in conjunction with a nebulizing device. Adverse reactions can be seen as taste disturbance, nausea, numbness of the mouth, numbness of the throat. It is contraindicated in people who are allergic to the components of the product. However, other dosage forms of Ambroxol, such as Ambroxol Injection, are not used for nebulized inhalation in the drug’s instruction manual, and therefore are not recommended for nebulized inhalation. The drug should be used rationally under the guidance of a doctor.